Low Libido

Definition

Low libido — clinically termed hypoactive sexual desire disorder (HSDD) when it causes personal distress — is one of the most common complaints in perimenopausal and postmenopausal women, estimated to affect 40 to 55% of women in this life stage. Contributing hormonal factors include declining testosterone, declining estrogen (which affects genital blood flow and sensitivity), low progesterone, elevated cortisol, and thyroid dysfunction. Physical contributors include vaginal dryness and pain (GSM), antidepressant use, blood pressure medications, and chronic illness. Psychological contributors include relationship factors, body image, and depression. Treatment requires identifying and addressing the primary drivers — which in midlife women is frequently hormonal — rather than recommending generic lifestyle advice.

Frequently Asked Question

What hormones are most associated with low libido in women?

Testosterone is the hormone most directly associated with sexual desire in women — its decline with aging and during menopause is a primary driver of reduced libido. Estrogen deficiency contributes indirectly by causing vaginal dryness and reduced genital sensation that makes sexual activity uncomfortable. Elevated cortisol — the stress hormone — suppresses the hormones that drive sexual desire. Thyroid dysfunction and progesterone deficiency also play roles. SPOKEmed evaluates all of these through comprehensive testing.

Can low libido be treated clinically?

Yes — especially when it has a primary hormonal cause. Testosterone therapy in appropriate doses for women can significantly restore sexual desire and arousal. Estrogen optimization addresses GSM-related pain that reduces motivation for sex. PT-141 (bremelanotide) is an FDA-approved medication for HSDD in premenopausal women that works on melanocortin receptors rather than hormones directly. The right treatment depends on identifying which factors are driving the low libido in your specific case.

Is it normal to lose interest in sex during menopause?

It is common — but it is not something you simply have to accept. The hormonal changes of menopause predictably affect libido through multiple pathways, all of which are clinically addressable. Treating the hormonal, physical, and relational contributors to low libido in midlife is part of evidence-based menopause care. Many women are surprised to discover that their libido returns significantly with appropriate hormonal support.

Why Low Libido Matters

Low libido is one of the most consistently underreported and undertreated symptoms in menopause care. Women frequently do not raise it, and clinicians frequently do not ask. Addressing it as a legitimate clinical issue with identifiable drivers improves patient outcomes, quality of life, and relationship health.

How Spokmed Company Uses It

SPOKEmed evaluates low libido within the context of full hormonal testing including testosterone, estrogen, and cortisol through the DUTCH test. Relevant interventions may include testosterone therapy, estrogen optimization, vaginal estrogen for GSM-related pain, and PT-141 peptide therapy when clinically appropriate.

Related Services

Related Terms

"Low Libido" Appears in These Categories

Hormone Health & Life Stage Transitions